Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Central Nervous System (CNS) Therapeutic Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Neurovascular
1.2.3 Trauma
1.2.4 Mental Health
1.2.5 Degenerative Disorder
1.2.6 Infections
1.2.7 Cancer
1.3 Market by Application
1.3.1 Global Central Nervous System (CNS) Therapeutic Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Clinical Application
1.3.3 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Central Nervous System (CNS) Therapeutic Market Perspective (2018-2033)
2.2 Central Nervous System (CNS) Therapeutic Growth Trends by Region
2.2.1 Global Central Nervous System (CNS) Therapeutic Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Central Nervous System (CNS) Therapeutic Historic Market Size by Region (2018-2023)
2.2.3 Central Nervous System (CNS) Therapeutic Forecasted Market Size by Region (2024-2033)
2.3 Central Nervous System (CNS) Therapeutic Market Dynamics
2.3.1 Central Nervous System (CNS) Therapeutic Industry Trends
2.3.2 Central Nervous System (CNS) Therapeutic Market Drivers
2.3.3 Central Nervous System (CNS) Therapeutic Market Challenges
2.3.4 Central Nervous System (CNS) Therapeutic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Central Nervous System (CNS) Therapeutic Players by Revenue
3.1.1 Global Top Central Nervous System (CNS) Therapeutic Players by Revenue (2018-2023)
3.1.2 Global Central Nervous System (CNS) Therapeutic Revenue Market Share by Players (2018-2023)
3.2 Global Central Nervous System (CNS) Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Central Nervous System (CNS) Therapeutic Revenue
3.4 Global Central Nervous System (CNS) Therapeutic Market Concentration Ratio
3.4.1 Global Central Nervous System (CNS) Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Central Nervous System (CNS) Therapeutic Revenue in 2022
3.5 Central Nervous System (CNS) Therapeutic Key Players Head office and Area Served
3.6 Key Players Central Nervous System (CNS) Therapeutic Product Solution and Service
3.7 Date of Enter into Central Nervous System (CNS) Therapeutic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Central Nervous System (CNS) Therapeutic Breakdown Data by Type
4.1 Global Central Nervous System (CNS) Therapeutic Historic Market Size by Type (2018-2023)
4.2 Global Central Nervous System (CNS) Therapeutic Forecasted Market Size by Type (2024-2033)
5 Central Nervous System (CNS) Therapeutic Breakdown Data by Application
5.1 Global Central Nervous System (CNS) Therapeutic Historic Market Size by Application (2018-2023)
5.2 Global Central Nervous System (CNS) Therapeutic Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Central Nervous System (CNS) Therapeutic Market Size (2018-2033)
6.2 North America Central Nervous System (CNS) Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Central Nervous System (CNS) Therapeutic Market Size by Country (2018-2023)
6.4 North America Central Nervous System (CNS) Therapeutic Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Central Nervous System (CNS) Therapeutic Market Size (2018-2033)
7.2 Europe Central Nervous System (CNS) Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Central Nervous System (CNS) Therapeutic Market Size by Country (2018-2023)
7.4 Europe Central Nervous System (CNS) Therapeutic Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Central Nervous System (CNS) Therapeutic Market Size (2018-2033)
8.2 Asia-Pacific Central Nervous System (CNS) Therapeutic Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Central Nervous System (CNS) Therapeutic Market Size by Region (2018-2023)
8.4 Asia-Pacific Central Nervous System (CNS) Therapeutic Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Central Nervous System (CNS) Therapeutic Market Size (2018-2033)
9.2 Latin America Central Nervous System (CNS) Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Central Nervous System (CNS) Therapeutic Market Size by Country (2018-2023)
9.4 Latin America Central Nervous System (CNS) Therapeutic Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size (2018-2033)
10.2 Middle East & Africa Central Nervous System (CNS) Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size by Country (2018-2023)
10.4 Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Central Nervous System (CNS) Therapeutic Introduction
11.1.4 Pfizer Revenue in Central Nervous System (CNS) Therapeutic Business (2018-2023)
11.1.5 Pfizer Recent Development
11.2 Biogen
11.2.1 Biogen Company Detail
11.2.2 Biogen Business Overview
11.2.3 Biogen Central Nervous System (CNS) Therapeutic Introduction
11.2.4 Biogen Revenue in Central Nervous System (CNS) Therapeutic Business (2018-2023)
11.2.5 Biogen Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Detail
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Central Nervous System (CNS) Therapeutic Introduction
11.3.4 Johnson & Johnson Revenue in Central Nervous System (CNS) Therapeutic Business (2018-2023)
11.3.5 Johnson & Johnson Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Company Detail
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Central Nervous System (CNS) Therapeutic Introduction
11.4.4 Eli Lilly Revenue in Central Nervous System (CNS) Therapeutic Business (2018-2023)
11.4.5 Eli Lilly Recent Development
11.5 Otsuka America Pharmaceutical
11.5.1 Otsuka America Pharmaceutical Company Detail
11.5.2 Otsuka America Pharmaceutical Business Overview
11.5.3 Otsuka America Pharmaceutical Central Nervous System (CNS) Therapeutic Introduction
11.5.4 Otsuka America Pharmaceutical Revenue in Central Nervous System (CNS) Therapeutic Business (2018-2023)
11.5.5 Otsuka America Pharmaceutical Recent Development
11.6 Merck
11.6.1 Merck Company Detail
11.6.2 Merck Business Overview
11.6.3 Merck Central Nervous System (CNS) Therapeutic Introduction
11.6.4 Merck Revenue in Central Nervous System (CNS) Therapeutic Business (2018-2023)
11.6.5 Merck Recent Development
11.7 Astrazeneca
11.7.1 Astrazeneca Company Detail
11.7.2 Astrazeneca Business Overview
11.7.3 Astrazeneca Central Nervous System (CNS) Therapeutic Introduction
11.7.4 Astrazeneca Revenue in Central Nervous System (CNS) Therapeutic Business (2018-2023)
11.7.5 Astrazeneca Recent Development
11.8 Novartis
11.8.1 Novartis Company Detail
11.8.2 Novartis Business Overview
11.8.3 Novartis Central Nervous System (CNS) Therapeutic Introduction
11.8.4 Novartis Revenue in Central Nervous System (CNS) Therapeutic Business (2018-2023)
11.8.5 Novartis Recent Development
11.9 Teva Pharmaceutical Industries
11.9.1 Teva Pharmaceutical Industries Company Detail
11.9.2 Teva Pharmaceutical Industries Business Overview
11.9.3 Teva Pharmaceutical Industries Central Nervous System (CNS) Therapeutic Introduction
11.9.4 Teva Pharmaceutical Industries Revenue in Central Nervous System (CNS) Therapeutic Business (2018-2023)
11.9.5 Teva Pharmaceutical Industries Recent Development
11.10 Takeda
11.10.1 Takeda Company Detail
11.10.2 Takeda Business Overview
11.10.3 Takeda Central Nervous System (CNS) Therapeutic Introduction
11.10.4 Takeda Revenue in Central Nervous System (CNS) Therapeutic Business (2018-2023)
11.10.5 Takeda Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Central Nervous System (CNS) Therapeutic Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Neurovascular
Table 3. Key Players of Trauma
Table 4. Key Players of Mental Health
Table 5. Key Players of Degenerative Disorder
Table 6. Key Players of Infections
Table 7. Key Players of Cancer
Table 8. Global Central Nervous System (CNS) Therapeutic Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Central Nervous System (CNS) Therapeutic Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 10. Global Central Nervous System (CNS) Therapeutic Market Size by Region (2018-2023) & (US$ Million)
Table 11. Global Central Nervous System (CNS) Therapeutic Market Share by Region (2018-2023)
Table 12. Global Central Nervous System (CNS) Therapeutic Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 13. Global Central Nervous System (CNS) Therapeutic Market Share by Region (2024-2033)
Table 14. Central Nervous System (CNS) Therapeutic Market Trends
Table 15. Central Nervous System (CNS) Therapeutic Market Drivers
Table 16. Central Nervous System (CNS) Therapeutic Market Challenges
Table 17. Central Nervous System (CNS) Therapeutic Market Restraints
Table 18. Global Central Nervous System (CNS) Therapeutic Revenue by Players (2018-2023) & (US$ Million)
Table 19. Global Central Nervous System (CNS) Therapeutic Market Share by Players (2018-2023)
Table 20. Global Top Central Nervous System (CNS) Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Central Nervous System (CNS) Therapeutic as of 2022)
Table 21. Ranking of Global Top Central Nervous System (CNS) Therapeutic Companies by Revenue (US$ Million) in 2022
Table 22. Global 5 Largest Players Market Share by Central Nervous System (CNS) Therapeutic Revenue (CR5 and HHI) & (2018-2023)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Central Nervous System (CNS) Therapeutic Product Solution and Service
Table 25. Date of Enter into Central Nervous System (CNS) Therapeutic Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Central Nervous System (CNS) Therapeutic Market Size by Type (2018-2023) & (US$ Million)
Table 28. Global Central Nervous System (CNS) Therapeutic Revenue Market Share by Type (2018-2023)
Table 29. Global Central Nervous System (CNS) Therapeutic Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 30. Global Central Nervous System (CNS) Therapeutic Revenue Market Share by Type (2024-2033)
Table 31. Global Central Nervous System (CNS) Therapeutic Market Size by Application (2018-2023) & (US$ Million)
Table 32. Global Central Nervous System (CNS) Therapeutic Revenue Market Share by Application (2018-2023)
Table 33. Global Central Nervous System (CNS) Therapeutic Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 34. Global Central Nervous System (CNS) Therapeutic Revenue Market Share by Application (2024-2033)
Table 35. North America Central Nervous System (CNS) Therapeutic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. North America Central Nervous System (CNS) Therapeutic Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Central Nervous System (CNS) Therapeutic Market Size by Country (2024-2033) & (US$ Million)
Table 38. Europe Central Nervous System (CNS) Therapeutic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 39. Europe Central Nervous System (CNS) Therapeutic Market Size by Country (2018-2023) & (US$ Million)
Table 40. Europe Central Nervous System (CNS) Therapeutic Market Size by Country (2024-2033) & (US$ Million)
Table 41. Asia-Pacific Central Nervous System (CNS) Therapeutic Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 42. Asia-Pacific Central Nervous System (CNS) Therapeutic Market Size by Region (2018-2023) & (US$ Million)
Table 43. Asia-Pacific Central Nervous System (CNS) Therapeutic Market Size by Region (2024-2033) & (US$ Million)
Table 44. Latin America Central Nervous System (CNS) Therapeutic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Latin America Central Nervous System (CNS) Therapeutic Market Size by Country (2018-2023) & (US$ Million)
Table 46. Latin America Central Nervous System (CNS) Therapeutic Market Size by Country (2024-2033) & (US$ Million)
Table 47. Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 48. Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size by Country (2024-2033) & (US$ Million)
Table 50. Pfizer Company Detail
Table 51. Pfizer Business Overview
Table 52. Pfizer Central Nervous System (CNS) Therapeutic Product
Table 53. Pfizer Revenue in Central Nervous System (CNS) Therapeutic Business (2018-2023) & (US$ Million)
Table 54. Pfizer Recent Development
Table 55. Biogen Company Detail
Table 56. Biogen Business Overview
Table 57. Biogen Central Nervous System (CNS) Therapeutic Product
Table 58. Biogen Revenue in Central Nervous System (CNS) Therapeutic Business (2018-2023) & (US$ Million)
Table 59. Biogen Recent Development
Table 60. Johnson & Johnson Company Detail
Table 61. Johnson & Johnson Business Overview
Table 62. Johnson & Johnson Central Nervous System (CNS) Therapeutic Product
Table 63. Johnson & Johnson Revenue in Central Nervous System (CNS) Therapeutic Business (2018-2023) & (US$ Million)
Table 64. Johnson & Johnson Recent Development
Table 65. Eli Lilly Company Detail
Table 66. Eli Lilly Business Overview
Table 67. Eli Lilly Central Nervous System (CNS) Therapeutic Product
Table 68. Eli Lilly Revenue in Central Nervous System (CNS) Therapeutic Business (2018-2023) & (US$ Million)
Table 69. Eli Lilly Recent Development
Table 70. Otsuka America Pharmaceutical Company Detail
Table 71. Otsuka America Pharmaceutical Business Overview
Table 72. Otsuka America Pharmaceutical Central Nervous System (CNS) Therapeutic Product
Table 73. Otsuka America Pharmaceutical Revenue in Central Nervous System (CNS) Therapeutic Business (2018-2023) & (US$ Million)
Table 74. Otsuka America Pharmaceutical Recent Development
Table 75. Merck Company Detail
Table 76. Merck Business Overview
Table 77. Merck Central Nervous System (CNS) Therapeutic Product
Table 78. Merck Revenue in Central Nervous System (CNS) Therapeutic Business (2018-2023) & (US$ Million)
Table 79. Merck Recent Development
Table 80. Astrazeneca Company Detail
Table 81. Astrazeneca Business Overview
Table 82. Astrazeneca Central Nervous System (CNS) Therapeutic Product
Table 83. Astrazeneca Revenue in Central Nervous System (CNS) Therapeutic Business (2018-2023) & (US$ Million)
Table 84. Astrazeneca Recent Development
Table 85. Novartis Company Detail
Table 86. Novartis Business Overview
Table 87. Novartis Central Nervous System (CNS) Therapeutic Product
Table 88. Novartis Revenue in Central Nervous System (CNS) Therapeutic Business (2018-2023) & (US$ Million)
Table 89. Novartis Recent Development
Table 90. Teva Pharmaceutical Industries Company Detail
Table 91. Teva Pharmaceutical Industries Business Overview
Table 92. Teva Pharmaceutical Industries Central Nervous System (CNS) Therapeutic Product
Table 93. Teva Pharmaceutical Industries Revenue in Central Nervous System (CNS) Therapeutic Business (2018-2023) & (US$ Million)
Table 94. Teva Pharmaceutical Industries Recent Development
Table 95. Takeda Company Detail
Table 96. Takeda Business Overview
Table 97. Takeda Central Nervous System (CNS) Therapeutic Product
Table 98. Takeda Revenue in Central Nervous System (CNS) Therapeutic Business (2018-2023) & (US$ Million)
Table 99. Takeda Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Central Nervous System (CNS) Therapeutic Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Central Nervous System (CNS) Therapeutic Market Share by Type: 2022 VS 2033
Figure 3. Neurovascular Features
Figure 4. Trauma Features
Figure 5. Mental Health Features
Figure 6. Degenerative Disorder Features
Figure 7. Infections Features
Figure 8. Cancer Features
Figure 9. Global Central Nervous System (CNS) Therapeutic Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 10. Global Central Nervous System (CNS) Therapeutic Market Share by Application: 2022 VS 2033
Figure 11. Clinical Application Case Studies
Figure 12. Others Case Studies
Figure 13. Central Nervous System (CNS) Therapeutic Report Years Considered
Figure 14. Global Central Nervous System (CNS) Therapeutic Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global Central Nervous System (CNS) Therapeutic Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global Central Nervous System (CNS) Therapeutic Market Share by Region: 2022 VS 2033
Figure 17. Global Central Nervous System (CNS) Therapeutic Market Share by Players in 2022
Figure 18. Global Top Central Nervous System (CNS) Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Central Nervous System (CNS) Therapeutic as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Central Nervous System (CNS) Therapeutic Revenue in 2022
Figure 20. North America Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America Central Nervous System (CNS) Therapeutic Market Share by Country (2018-2033)
Figure 22. United States Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Central Nervous System (CNS) Therapeutic Market Share by Country (2018-2033)
Figure 26. Germany Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. France Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. U.K. Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Italy Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Russia Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Nordic Countries Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific Central Nervous System (CNS) Therapeutic Market Share by Region (2018-2033)
Figure 34. China Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Japan Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. South Korea Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Southeast Asia Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. India Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Australia Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America Central Nervous System (CNS) Therapeutic Market Share by Country (2018-2033)
Figure 42. Mexico Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Brazil Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa Central Nervous System (CNS) Therapeutic Market Share by Country (2018-2033)
Figure 46. Turkey Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Saudi Arabia Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Pfizer Revenue Growth Rate in Central Nervous System (CNS) Therapeutic Business (2018-2023)
Figure 49. Biogen Revenue Growth Rate in Central Nervous System (CNS) Therapeutic Business (2018-2023)
Figure 50. Johnson & Johnson Revenue Growth Rate in Central Nervous System (CNS) Therapeutic Business (2018-2023)
Figure 51. Eli Lilly Revenue Growth Rate in Central Nervous System (CNS) Therapeutic Business (2018-2023)
Figure 52. Otsuka America Pharmaceutical Revenue Growth Rate in Central Nervous System (CNS) Therapeutic Business (2018-2023)
Figure 53. Merck Revenue Growth Rate in Central Nervous System (CNS) Therapeutic Business (2018-2023)
Figure 54. Astrazeneca Revenue Growth Rate in Central Nervous System (CNS) Therapeutic Business (2018-2023)
Figure 55. Novartis Revenue Growth Rate in Central Nervous System (CNS) Therapeutic Business (2018-2023)
Figure 56. Teva Pharmaceutical Industries Revenue Growth Rate in Central Nervous System (CNS) Therapeutic Business (2018-2023)
Figure 57. Takeda Revenue Growth Rate in Central Nervous System (CNS) Therapeutic Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed